14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 85 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BIOVF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Swedish Orphan Biovitrum AB (publ) Stock and on which exchange is it traded?
The symbol for Swedish Orphan Biovitrum AB (publ) is BIOVF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Swedish Orphan Biovitrum AB (publ) Stock?
Swedish Orphan Biovitrum AB (publ) holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Swedish Orphan Biovitrum AB (publ) Stock?
Swedish Orphan Biovitrum AB (publ) Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Swedish Orphan Biovitrum AB (publ) Stock.

What's the current price of Swedish Orphan Biovitrum AB (publ) Stock?
As of the end of day on the May 17, 2024, the price of an Swedish Orphan Biovitrum AB (publ) (BIOVF) share was $25.76.

What is the 52-week high and low for Swedish Orphan Biovitrum AB (publ) Stock?
The 52-week high for Swedish Orphan Biovitrum AB (publ) Stock is $27.79 and the 52-week low is $18.35.

What is the market capitalization of Swedish Orphan Biovitrum AB (publ) Stock?
As of the May 17, 2024, the market capitalization of Swedish Orphan Biovitrum AB (publ) is 8.754B.

When is the next earnings date for Swedish Orphan Biovitrum AB (publ)?
The upcoming earnings date for Swedish Orphan Biovitrum AB (publ) is Jul 16, 2024.
Click to get the best stock tips daily for free!

About Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ) Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin ... BIOVF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT